David McIntyre

David McIntyre

Directeur Financier/CFO chez BRAEBURN INC.

Fortune : 153 116 $ au 31/10/2026

55 ans
Health Technology
Commercial Services
Consumer Services

Profil

David John McIntyre currently works at Starpharma Holdings Ltd., as Deputy Chairman from 2026, Vytronus, Inc., as Director from 2014, Tendyne Holdings, Inc., as Director, Braeburn, Inc., as Treasurer, Chief Financial Officer, Director & EVP from 2016, Petalion Therapeutics Ltd., as Director, Fisher House Foundation, Inc., as Trustee from 2010, The Law Society of New South Wales, as Member, and Inhibikase Therapeutics, Inc., as Chief Financial Officer from 2025.
Mr. McIntyre also formerly worked at Avedro, Inc., as Director, Gala Therapeutics, Inc., as Director, Tusker Medical, Inc., as Director, Redflex Holdings Pty Ltd., as Independent Non-Executive Director, ROX Medical, Inc., as Non-Executive Director, Heartware Pty Ltd., as CFO, Secretary & Chief Business Officer, Baker & McKenzie LLP (Illinois), as Senior Attorney, KPMG Legal, as Senior Attorney in 2003, AVITA Medical Pty Ltd., as Chief Financial Officer from 2019 to 2020, HeartWare International, Inc., as Chief Operating & Financial Officer & Executive VP in 2011, Tessa Therapeutics Ltd, as Chief Financial Officer from 2020 to 2021, Anthos Therapeutics, Inc., as Chief Financial Officer from 2021 to 2024, AVITA Medical, Inc., as Chief Financial Officer, and Apple Tree Venture Management Llc, as Partner from 2012 to 2020.
Mr. McIntyre received his undergraduate degree from The University of Sydney, graduate degree from the University of Technology Sydney, and Masters Business Admin degree from The Fuqua School of Business.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/06/2025 433 299 ( 0,09 % ) 137 174 $ 31/10/2026
15/04/2026 10 285 ( 0,01 % ) 15 942 $ 31/10/2026

Postes actifs de David McIntyre

SociétésPosteDébut
BRAEBURN INC. Directeur Financier/CFO 01/10/2016
INHIBIKASE THERAPEUTICS, INC. Directeur Financier/CFO 14/04/2025
STARPHARMA HOLDINGS LIMITED Directeur/Membre du Conseil 01/03/2020
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 30/10/2014
Directeur/Membre du Conseil -
The Law Society of New South Wales
Corporate Officer/Principal -

Anciens postes connus de David McIntyre

SociétésPosteFin
Directeur Financier/CFO 01/10/2024
Directeur Financier/CFO 01/10/2021
░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de David McIntyre

Formation de David McIntyre

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

24

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées24

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Finance

Commercial Services

The Law Society of New South Wales

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David McIntyre
🔇